Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
John J. Suschak & Connie S. Schmaljohn. (2019) Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates. Human Vaccines & Immunotherapeutics 15:10, pages 2359-2377.
Read now
Read now
Raj Kumar Singh, Kuldeep Dhama, Yashpal Singh Malik, Muthannan Andavar Ramakrishnan, Kumaragurubaran Karthik, Rekha Khandia, Ruchi Tiwari, Ashok Munjal, Mani Saminathan, Swati Sachan, Perumal Arumugam Desingu, Jobin Jose Kattoor, Hafiz M.N. Iqbal & Sunil Kumar Joshi. (2017) Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey. Veterinary Quarterly 37:1, pages 98-135.
Read now
Read now
Thomas Hoenen & Heinz Feldmann. (2014) Reverse genetics systems as tools for the development of novel therapies against filoviruses. Expert Review of Anti-infective Therapy 12:10, pages 1253-1263.
Read now
Read now
Andrea Marzi & Heinz Feldmann. (2014) Ebola virus vaccines: an overview of current approaches. Expert Review of Vaccines 13:4, pages 521-531.
Read now
Read now
Articles from other publishers (54)
Catherine Yankowski, Drishya Kurup, Christoph Wirblich & Matthias J. Schnell. (2023) Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. npj Vaccines 8:1.
Crossref
Crossref
Saurabh Gautam, Dongyue Xin, Alan Pardo Garcia & Bart Spiesschaert. (2022) Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Roberto Biselli, Roberto Nisini, Florigio Lista, Alberto Autore, Marco Lastilla, Giuseppe De Lorenzo, Mario Stefano Peragallo, Tommaso Stroffolini & Raffaele D’Amelio. (2022) A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health. Biomedicines 10:8, pages 2050.
Crossref
Crossref
Ashish Ranjan Sharma, Yeon-Hee Lee, Sudarshini Nath & Sang-Soo Lee. (2021) Recent developments and strategies of Ebola virus vaccines. Current Opinion in Pharmacology 60, pages 46-53.
Crossref
Crossref
Collins Kipkorir Kebenei & Patrick Okoth. (2021) Ebola Virus Disease, Diagnostics and Therapeutics: Where is the Consensus in Over Three Decades of Clinical Research?. Scientific African 13, pages e00862.
Crossref
Crossref
Flávio Figueira, Jéssica S. Barbosa, Ricardo F. Mendes, Susana S. Braga & Filipe A. Almeida Paz. (2021) Virus meet metal-organic frameworks: A nanoporous solution to a world-sized problem?. Materials Today 43, pages 84-98.
Crossref
Crossref
Mujahed I. Mustafa, Shaza W. Shantier, Miyssa I. Abdelmageed & Abdelrafie M. Makhawi. (2021) Epitope-based peptide vaccine against Bombali Ebolavirus viral protein 40: An immunoinformatics combined with molecular docking studies. Informatics in Medicine Unlocked 25, pages 100694.
Crossref
Crossref
Sahar Qazi, Ayesha Khanam & Khalid Raza. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
123
142
.
Milagritos D. Tapia, Moussa Doumbia, Rokiatou Dembele, Karen Ball, Birahim N'Diaye, Haoua Amadou, Sarah Charara, Ana Maria Henao-Restrepo, Corinne S. Merle, Samba O. Sow & Myron M. Levine. (2020) Arranging good clinical practices training and trial monitoring for a vaccine efficacy study during a public health emergency of international concern. Vaccine 38:24, pages 4050-4056.
Crossref
Crossref
Lindi Mathebula, Duduzile Edith Ndwandwe, Elizabeth Pienaar & Charles Shey Wiysonge. (2019) Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review. BMJ Open 9:7, pages e029617.
Crossref
Crossref
Sahil Jain & Manoj Baranwal. (2019) Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules. Journal of Theoretical Biology 465, pages 34-44.
Crossref
Crossref
Raffaele Riccò, Weibin Liang, Shaobo Li, Jeremiah J. Gassensmith, Frank Caruso, Christian Doonan & Paolo Falcaro. (2018) Metal–Organic Frameworks for Cell and Virus Biology: A Perspective. ACS Nano 12:1, pages 13-23.
Crossref
Crossref
Nicholas J. Lennemann, Andrew S. Herbert, Rachel Brouillette, Bethany Rhein, Russell A. Bakken, Katherine J. Perschbacher, Ashley L. Cooney, Catherine L. Miller-Hunt, Patrick Ten Eyck, Julia Biggins, Gene Olinger, John M. Dye & Wendy Maury. (2017) Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice. Journal of Virology 91:17.
Crossref
Crossref
Joseph Masci & Elizabeth Bass. 2017. Ebola. Ebola
135
143
.
Sergio Rosales-Mendoza, Ricardo Nieto-Gómez & Carlos Angulo. (2017) A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus. Frontiers in Immunology 8.
Crossref
Crossref
Regina Ríos-Huerta, Elizabeth Monreal-Escalante, Dania O. Govea-Alonso, Carlos Angulo & Sergio Rosales-Mendoza. (2016) Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells. Plant Cell Reports 36:2, pages 355-365.
Crossref
Crossref
Jayasree Ganugapati & Sai Akash. (2017) Multi-template homology based structure prediction and molecular docking studies of protein ‘L’ of Zaire ebolavirus (EBOV). Informatics in Medicine Unlocked 9, pages 68-75.
Crossref
Crossref
Daniela Alexandra de Meneses Rocha Aguiar Pacheco, Acácio Agostinho Gonçalves Rodrigues & Carmen Maria Lisboa da Silva. (2016) Ebola virus – from neglected threat to global emergency state. Revista da Associação Médica Brasileira 62:5, pages 458-467.
Crossref
Crossref
Huijun Xi, Jie Cao, Jingjing Liu, Zhaoshen Li, Xiangyu Kong, Yonghua Wang, Jing Chen, Su Ma & Lingjuan Zhang. (2016) Improving health care workers' protection against infection of Ebola hemorrhagic fever through video surveillance. American Journal of Infection Control 44:8, pages 922-924.
Crossref
Crossref
Muhammad Asif Zahoor, Mohsin Khurshid, Rabia Qureshi, Aneeqa Naz & Muhammad Shahid. (2016) Cell culture-based viral vaccines: current status and future prospects. Future Virology 11:7, pages 549-562.
Crossref
Crossref
Jay B. Varkey & Bruce S. Ribner. 2016. Emerging Infections 10. Emerging Infections 10
39
52
.
Jay B. Varkey & Bruce S. Ribner. (2016) Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us. Microbiology Spectrum 4:3.
Crossref
Crossref
Elijah Ige Ohimain. (2016) Recent advances in the development of vaccines for Ebola virus disease. Virus Research 211, pages 174-185.
Crossref
Crossref
Rebecca Reece, Michael A. Smit & Timothy P. Flanigan. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
355
362
.
Sunil Thomas, Rima Dilbarova & Rino Rappuoli. 2016. Vaccine Design. Vaccine Design
41
55
.
Gurpreet Singh, Arbind Kumar, Kashmir Singh & Jagdeep Kaur. (2016) Ebola virus: an introduction and its pathology. Reviews in Medical Virology 26:1, pages 49-56.
Crossref
Crossref
Kunisuke Izawa, José Luis Aceña, Jiang Wang, Vadim A. Soloshonok & Hong Liu. (2016) Small-Molecule Therapeutics for Ebola Virus (EBOV) Disease Treatment. European Journal of Organic Chemistry 2016:1, pages 8-16.
Crossref
Crossref
Audrey Stéphanie Richard, Adam Zhang, Sun-Jin Park, Michael Farzan, Min Zong & Hyeryun Choe. (2015) Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proceedings of the National Academy of Sciences 112:47, pages 14682-14687.
Crossref
Crossref
Carles Martínez-Romero & Adolfo García-Sastre. (2015) Against the clock towards new Ebola virus therapies. Virus Research 209, pages 4-10.
Crossref
Crossref
Zlatko Janeba. (2015) Development of Small-Molecule Antivirals for Ebola. Medicinal Research Reviews 35:6, pages 1175-1194.
Crossref
Crossref
Nishant K. Jain, Neha Sahni, Ozan S. Kumru, Sangeeta B. Joshi, David B. Volkin & C. Russell Middaugh. (2015) Formulation and stabilization of recombinant protein based virus-like particle vaccines. Advanced Drug Delivery Reviews 93, pages 42-55.
Crossref
Crossref
Arafat Rahman Oany, Tahmina Sharmin, Afrin Sultana Chowdhury, Tahmina Pervin Jyoti & Md. Anayet Hasan. (2015) Highly conserved regions in Ebola virus RNA dependent RNA polymerase may be act as a universal novel peptide vaccine target: a computational approach. In Silico Pharmacology 3:1.
Crossref
Crossref
Jin Huk Choi, Stephen C. Schafer, Alexander N. Freiberg & Maria A. Croyle. (2015) Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine. Molecular Pharmaceutics 12:8, pages 2697-2711.
Crossref
Crossref
M. A. Khan, M. U. Hossain, S. M. Rakib-Uz-Zaman & M. N. Morshed. (2015) Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study. Scandinavian Journal of Immunology 82:1, pages 25-34.
Crossref
Crossref
Chad Wells, Dan Yamin, Martial L. Ndeffo-Mbah, Natasha Wenzel, Stephen G. Gaffney, Jeffrey P. Townsend, Lauren Ancel Meyers, Mosoka Fallah, Tolbert G. Nyenswah, Frederick L. Altice, Katherine E. Atkins & Alison P. Galvani. (2015) Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLOS Neglected Tropical Diseases 9:5, pages e0003794.
Crossref
Crossref
J. Reina & A. Iñigo. (2015) Situación actual de las vacunas frente al virus del Ébola. Vacunas 16:2, pages 56-64.
Crossref
Crossref
Mercedes Torres, Karen N. Hansen & David Jerrard. (2015) Ebola. Emergency Medicine Clinics of North America 33:2, pages e1-e18.
Crossref
Crossref
Saurabh RamBihariLal Shrivastava, Prateek Saurabh Shrivastava & Jegadeesh Ramasamy. (2015) Ebola disease: an international public health emergency. Asian Pacific Journal of Tropical Disease 5:4, pages 253-262.
Crossref
Crossref
Natarajan Ayithan, Steven B. Bradfute, Scott M. Anthony, Kelly S. Stuthman, Sina Bavari, Mike Bray & Keiko Ozato. (2015) Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection. PLOS ONE 10:2, pages e0118345.
Crossref
Crossref
M. M. Levine, M. Tapia, A. V. Hill & S. O. Sow. (2014) How the Current West African Ebola Virus Disease Epidemic Is Altering Views on the Need for Vaccines and Is Galvanizing a Global Effort to Field-Test Leading Candidate Vaccines. Journal of Infectious Diseases 211:4, pages 504-507.
Crossref
Crossref
Haoyang Li, Tianlei Ying, Fei Yu, Lu Lu & Shibo Jiang. (2015) Development of therapeutics for treatment of Ebola virus infection. Microbes and Infection 17:2, pages 109-117.
Crossref
Crossref
Ariel Sobarzo, Yael Eskira, Andrew Herbert, Ana Kuehne, Spencer Stonier, David Ochayon, Shlomit Fedida-Metula, Steven Balinandi, Yaara Kislev, Neta Tali, Eli Lewis, Julius Lutwama, John Dye, Victoria Yavelsky & Leslie Lobel. (2015) Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks. Viruses 7:1, pages 37-51.
Crossref
Crossref
Woo Young Choi, Kee-Jong Hong, Joo Eun Hong & Won-Ja Lee. (2015) Progress of vaccine and drug development for Ebola preparedness. Clinical and Experimental Vaccine Research 4:1, pages 11.
Crossref
Crossref
Jennifer E Gallagher, Patric Don-Davis & Stephen J Challacombe. (2015) Ebola and care in the front line. Faculty Dental Journal 6:1, pages 18-23.
Crossref
Crossref
Hinrich Sudeck. 2015. Reisedermatosen. Reisedermatosen
89
99
.
Pritish K. Tosh & Priya Sampathkumar. (2014) What Clinicians Should Know About the 2014 Ebola Outbreak. Mayo Clinic Proceedings 89:12, pages 1710-1717.
Crossref
Crossref
Aftab A. Ansari. (2014) Clinical features and pathobiology of Ebolavirus infection. Journal of Autoimmunity 55, pages 1-9.
Crossref
Crossref
Jason Kindrachuk, Victoria Wahl-Jensen, David Safronetz, Brett Trost, Thomas Hoenen, Ryan Arsenault, Friederike Feldmann, Dawn Traynor, Elena Postnikova, Anthony Kusalik, Scott Napper, Joseph E. Blaney, Heinz Feldmann & Peter B. Jahrling. (2014) Ebola Virus Modulates Transforming Growth Factor β Signaling and Cellular Markers of Mesenchyme-Like Transition in Hepatocytes. Journal of Virology 88:17, pages 9877-9892.
Crossref
Crossref
Jean-Philippe Chippaux. (2014) Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. Journal of Venomous Animals and Toxins including Tropical Diseases 20:1, pages 44.
Crossref
Crossref
Lucille Blumberg, Delia Enria & Daniel G. Bausch. 2014. Manson's Tropical Infectious Diseases. Manson's Tropical Infectious Diseases
171
194.e2
.
Jin Huk Choi, Stephen C. Schafer, Lihong Zhang, Terry Juelich, Alexander N. Freiberg & Maria A. Croyle. (2013) Modeling Pre-Existing Immunity to Adenovirus in Rodents: Immunological Requirements for Successful Development of a Recombinant Adenovirus Serotype 5-Based Ebola Vaccine. Molecular Pharmaceutics 10:9, pages 3342-3355.
Crossref
Crossref
Xiangguo Qiu, Gary Wong, Lisa Fernando, Jane Ennis, Jeffrey D. Turner, Judie B. Alimonti, Xiaojian Yao & Gary P. Kobinger. (2013) Monoclonal Antibodies Combined with Adenovirus-Vectored Interferon Significantly Extend the Treatment Window in Ebola Virus-Infected Guinea Pigs. Journal of Virology 87:13, pages 7754-7757.
Crossref
Crossref
Thomas Hoenen. 2013. Molecular Vaccines. Molecular Vaccines
119
134
.
Leslie P. Silva, Michael Vanzile, Sina Bavari, J. M. Javad Aman & David C. Schriemer. (2012) Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails. PLoS ONE 7:7, pages e39978.
Crossref
Crossref